Upload
Featured Recent Articles Topics Login Upload

Search Results for 'study ftc'

study ftc published presentations and documents on DocSlides.

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial
Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial
by keanu817
RADAR Trial. Raltegravir. + Darunavir/r versus TD...
Elvitegravir-Cobicistat-TAF-FTC in Hepatitis B Coinfection
Elvitegravir-Cobicistat-TAF-FTC in Hepatitis B Coinfection
by melanie
Study 1249. Elvitegravir-Cobicistat-TAF-FTC in HIV...
Switch to EVG/c/FTC/TDF
Switch to EVG/c/FTC/TDF
by liane-varnes
STRATEGY-PI . Study. STRATEGY-NNRTI . Study. Desi...
Phase 2 of new ARVs
Phase 2 of new ARVs
by mitsue-stanley
Fostemsavir. , . prodrug. of . temsavir. . (. a...
Pre-exposure Prophylaxis for HIV Prevention
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
Tenofovir
Tenofovir
by alida-meadow
based . PrEP. technologies in women : . what do...
Switch to LPV/
Switch to LPV/
by lindy-dunigan
r. + 3TC. OLE . Study. LPV/. r. bid + 3TC or FT...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...
NRTI-sparing
NRTI-sparing
by liane-varnes
SPARTAN. PROGRESS. RADAR. NEAT001/ANRS 14. 3. A40...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by cheryl-pisano
FLAMINGO. GS-236-0103. ACTG A5257. WAVES . ARIA ....
Clinical Management Module
Clinical Management Module
by stefany-barnette
4. . (b) . Risks and Side Effects. Overview. Res...
ART Initiation: PrEP and
ART Initiation: PrEP and
by alida-meadow
Treatment-naïve Patients . Clinical Instructor, ...
Fixed-Dose Combination of
Fixed-Dose Combination of
by myesha-ticknor
Doravirine. /Lamivudine/TDF is Non-Inferior to . ...
What’s Next – and When:
What’s Next – and When:
by sherrill-nordquist
An Update on Injectable . P. revention. Alex R Ri...
Comparison of NNRTI vs NNRTI
Comparison of NNRTI vs NNRTI
by lindy-dunigan
ENCORE. EFV vs RPV. ECHO-THRIVE. STAR. EFV vs ETR...
Comparison of INSTI vs EFV
Comparison of INSTI vs EFV
by mediumgeneral
STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...
CROI Update: Best of Boston
CROI Update: Best of Boston
by triclin
p. resented by. NCATEC. March . 18, . 2014. David ...
Switch to LPV/ r + 3TC OLE
Switch to LPV/ r + 3TC OLE
by susan2
Study. LPV/. r. bid + 3TC or FTC . qd. + NRTI. N ...
Generic tenofovir disoproxil
Generic tenofovir disoproxil
by SunkissedBabe
fumarate and . emtricitabine. tablets obtained fr...
GS-US-380-1878 GS-US-380-1844
GS-US-380-1878 GS-US-380-1844
by phoebe
GS-US-380-1961. . Switch to BIC/FTC/TAF. Design...
Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)
Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)
by zane419
Study 105. Atazanavir + [Cobicistat or Ritonavir] ...
ADOLESCENT PrEP STUDIES
ADOLESCENT PrEP STUDIES
by min-jolicoeur
. . Shorai. . Mukaka. , . MBchB. ...
Switch to ATV/
Switch to ATV/
by cheryl-pisano
r. + RAL. HARNESS Study. ATV/. r. 300/100 mg ....
The Bangkok Tenofovir Study
The Bangkok Tenofovir Study
by marina-yarberry
An HIV pre-exposure prophylaxis trial in Thailand...
Innovative Strategies for the Management
Innovative Strategies for the Management
by karlyn-bohler
of HIV Infection. Dual therapies without NRTIs. J...
A C omparison of Daily
A C omparison of Daily
by debby-jeon
and . Non-daily . Pre-exposure . P. rophylaxis Do...
Maraviroc ( Selzentry ) Prepared by:
Maraviroc ( Selzentry ) Prepared by:
by amelia
David H. Spach, MD. Brian R. Wood, MD. Last Update...
Switching to Bictegravir
Switching to Bictegravir
by emery
/. Emtricitabine. /. Tenofovir. . Alafenamide. (...
Comparison of NNRTI vs NNRTI
Comparison of NNRTI vs NNRTI
by tatyana-admore
ENCORE. EFV vs RPV. ECHO-THRIVE. STAR. EFV vs ETR...
ART as prevention: PEP &
ART as prevention: PEP &
by phoebe-click
PrEP. Dr. Laura Waters. HIV/GU Medicine. Brighto...
CROI 2015: HIV Prevention Updates
CROI 2015: HIV Prevention Updates
by pamella-moone
Ruanne V Barnabas, . MBChB. . Dphil. Global Heal...
ID Week 2016: HIV Update
ID Week 2016: HIV Update
by min-jolicoeur
Robert Harrington, M.D.. ID Week 2016: HIV Update...
Comparison of INSTI vs INSTI
Comparison of INSTI vs INSTI
by pamella-moone
QDMRK. SPRING-2. ONCEMRK. ONCEMRK. Design. Object...
Characteristics and Oral
Characteristics and Oral
by lois-ondreau
PrEP. Adherence in the TDF2 Open-Label Extension...
Highlights for clinical
Highlights for clinical
by pasty-toler
. practice. HIV. International Congress of Drug ...
Modifying Therapy in the Treatment-experienced Patient:
Modifying Therapy in the Treatment-experienced Patient:
by yoshiko-marsland
When should it be done?. Professor of Medicine. U...
Essentials for Optimal Care of HIV Patients
Essentials for Optimal Care of HIV Patients
by marina-yarberry
Evidence-Based Approaches. Simply Speaking. ®. ...
Comparison of PI vs PI ATV vs ATV/r BMS 089
Comparison of PI vs PI ATV vs ATV/r BMS 089
by phoebe-click
LPV/r mono vs LPV/r ZDV/3TC MONARK. LPV/r QD v...
Non-Aids related co-morbidities
Non-Aids related co-morbidities
by disclaimercanon
Godelieve. de Bree. Internist-. infectiologist. ,...